Literature DB >> 11861682

Genetic effects on human cognition: lessons from the study of mental retardation syndromes.

P Nokelainen1, J Flint.   

Abstract

The molecular basis of human cognition is still poorly understood, but recent advances in finding genetic mutations that result in cognitive impairment may provide insights into the neurobiology of cognitive function. Here we review the progress that has been made so far and assess what has been learnt from this work on the relation between genes and cognitive processes. We review evidence that the pathway from genetic lesion to cognitive impairment can be dissected, that some genetic effects on cognition are relatively direct and we argue that the study of mental retardation syndromes is giving us new clues about the biological bases of cognition.

Entities:  

Mesh:

Year:  2002        PMID: 11861682      PMCID: PMC1737778          DOI: 10.1136/jnnp.72.3.287

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  121 in total

1.  Fragile X genotype characterized by an unstable region of DNA.

Authors:  S Yu; M Pritchard; E Kremer; M Lynch; J Nancarrow; E Baker; K Holman; J C Mulley; S T Warren; D Schlessinger
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

2.  Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA.

Authors:  J D Lewis; R R Meehan; W J Henzel; I Maurer-Fogy; P Jeppesen; F Klein; A Bird
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

3.  Familial aggregation of a developmental language disorder.

Authors:  M Gopnik; M B Crago
Journal:  Cognition       Date:  1991-04

4.  Genetic basis of grammar defect.

Authors:  M Gopnik
Journal:  Nature       Date:  1990-09-06       Impact factor: 49.962

5.  Analysis of neocortex in three males with the fragile X syndrome.

Authors:  V J Hinton; W T Brown; K Wisniewski; R D Rudelli
Journal:  Am J Med Genet       Date:  1991-12-01

6.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.

Authors:  A J Verkerk; M Pieretti; J S Sutcliffe; Y H Fu; D P Kuhl; A Pizzuti; O Reiner; S Richards; M F Victoria; F P Zhang
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

7.  Periventricular leukomalacia: ultrasonic and neuropathological correlations.

Authors:  J Rodriguez; D Claus; G Verellen; G Lyon
Journal:  Dev Med Child Neurol       Date:  1990-04       Impact factor: 5.449

8.  Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.

Authors: 
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

9.  Absence of expression of the FMR-1 gene in fragile X syndrome.

Authors:  M Pieretti; F P Zhang; Y H Fu; S T Warren; B A Oostra; C T Caskey; D L Nelson
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

10.  The role of Rab3A in neurotransmitter release.

Authors:  M Geppert; V Y Bolshakov; S A Siegelbaum; K Takei; P De Camilli; R E Hammer; T C Südhof
Journal:  Nature       Date:  1994-06-09       Impact factor: 49.962

View more
  3 in total

Review 1.  Human brain evolution and the "Neuroevolutionary Time-depth Principle:" Implications for the Reclassification of fear-circuitry-related traits in DSM-V and for studying resilience to warzone-related posttraumatic stress disorder.

Authors:  H Stefan Bracha
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-03-23       Impact factor: 5.067

Review 2.  Neuropsychiatric syndromes in adults with intellectual disability: issues in assessment and treatment.

Authors:  Richard B Ferrell; Eve J Wolinsky; Christopher I Kauffman; Laura A Flashman; Thomas W McAllister
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

3.  Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.

Authors:  Geana Paula Kurita; Ola Ekholm; Stein Kaasa; Pål Klepstad; Frank Skorpen; Per Sjøgren
Journal:  Brain Behav       Date:  2016-05-03       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.